New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Can herbal remedies provide an effective treatment option for children with irritable bowel syndrome

Can herbal remedies provide an effective treatment option for children with irritable bowel syndrome

ByPooja Toshniwal PahariaOct 16 2023Reviewed byLily Ramsey, LLMIn a recent review published inNutrients, researchers examined recent studies on the positive effectsand adverse
World medicine November 24,2023
Can herbal remedies provide an effective treatment option for children with irritable bowel syndrome

Can herbal remedies provide an effective treatment option for children with irritable bowel syndrome

ByPooja Toshniwal PahariaOct 16 2023Reviewed byLily Ramsey, LLMIn a recent review published inNutrients, researchers examined recent studies on the positive effectsand adverse
World medicine November 24,2023
Obesity linked to prostate cancer risk: New study uncovers inherited dangers from fathers

Obesity linked to prostate cancer risk: New study uncovers inherited dangers from fathers

ByHugo Francisco de SouzaNov 23 2023Reviewed bySusha Cheriyedath, M.Sc.In a recent review published in the journalNutrients,researchers investigated available literature on the
World medicine November 24,2023
Obesity linked to prostate cancer risk: New study uncovers inherited dangers from fathers

Obesity linked to prostate cancer risk: New study uncovers inherited dangers from fathers

ByHugo Francisco de SouzaNov 23 2023Reviewed bySusha Cheriyedath, M.Sc.In a recent review published in the journalNutrients,researchers investigated available literature on the
World medicine November 24,2023
Obesity linked to worse menopause symptoms and less effective hormone therapy

Obesity linked to worse menopause symptoms and less effective hormone therapy

Reviewed byMegan Craig, M.Sc.Sep 27 2023Obesity has already been associated with a number of adverse health conditions and can interfere with a person's quality of life. A new study suggests
World medicine November 24,2023
Obesity linked to worse menopause symptoms and less effective hormone therapy

Obesity linked to worse menopause symptoms and less effective hormone therapy

Reviewed byMegan Craig, M.Sc.Sep 27 2023Obesity has already been associated with a number of adverse health conditions and can interfere with a person's quality of life. A new study suggests
World medicine November 24,2023
AI model predicts lung cancer risk in never-smokers using routine chest X-rays

AI model predicts lung cancer risk in never-smokers using routine chest X-rays

Nov 22 2023Radiological Society of North AmericaUsing a routine chest X-ray image, an artificial intelligence (AI) tool can identify non-smokers who are at high risk for lung cancer, according to a st
World medicine November 24,2023
AI model predicts lung cancer risk in never-smokers using routine chest X-rays

AI model predicts lung cancer risk in never-smokers using routine chest X-rays

Nov 22 2023Radiological Society of North AmericaUsing a routine chest X-ray image, an artificial intelligence (AI) tool can identify non-smokers who are at high risk for lung cancer, according to a st
World medicine November 24,2023
Ongoing Research Aims to Bring Bispecific Antibodies to Earlier Settings and Novel Combinations in Myeloma

Ongoing Research Aims to Bring Bispecific Antibodies to Earlier Settings and Novel Combinations in Myeloma

November 21, 2023Ryan ScottJoshua Richter, MD, provides an overview of the current state of bispecific antibodies in multiple myeloma, discusses ongoing investigations of these agents, and expands on
World medicine November 23,2023
Ongoing Research Aims to Bring Bispecific Antibodies to Earlier Settings and Novel Combinations in Myeloma

Ongoing Research Aims to Bring Bispecific Antibodies to Earlier Settings and Novel Combinations in Myeloma

November 21, 2023Ryan ScottJoshua Richter, MD, provides an overview of the current state of bispecific antibodies in multiple myeloma, discusses ongoing investigations of these agents, and expands on
World medicine November 23,2023
Zanubrutinib Plus Obinutuzumab Approaches EU Approval in R/R Follicular Lymphoma

Zanubrutinib Plus Obinutuzumab Approaches EU Approval in R/R Follicular Lymphoma

October 13, 2023Kristi RosaThe European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended the approval of zanubrutinib in combination with obinutuzumab for use in adult
World medicine November 23,2023
Zanubrutinib Plus Obinutuzumab Approaches EU Approval in R/R Follicular Lymphoma

Zanubrutinib Plus Obinutuzumab Approaches EU Approval in R/R Follicular Lymphoma

October 13, 2023Kristi RosaThe European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended the approval of zanubrutinib in combination with obinutuzumab for use in adult
World medicine November 23,2023
Addition of Doxorubicin to Zalifrelimab/Balstilimab Leads to Responses in Advanced Soft Tissue Sarcoma

Addition of Doxorubicin to Zalifrelimab/Balstilimab Leads to Responses in Advanced Soft Tissue Sarcoma

August 24, 2023Ryan ScottBreelyn Wilky, MD, discusses the rationale for investigating the addition of doxorubicin to zalifrelimab and balstilimab in patients with advanced/metastatic soft tissue sarco
World medicine November 23,2023
Addition of Doxorubicin to Zalifrelimab/Balstilimab Leads to Responses in Advanced Soft Tissue Sarcoma

Addition of Doxorubicin to Zalifrelimab/Balstilimab Leads to Responses in Advanced Soft Tissue Sarcoma

August 24, 2023Ryan ScottBreelyn Wilky, MD, discusses the rationale for investigating the addition of doxorubicin to zalifrelimab and balstilimab in patients with advanced/metastatic soft tissue sarco
World medicine November 23,2023
First-Line TPST-1120 Plus Atezolizumab/Bevacizumab Improves Responses in Unresectable or Metastatic HCC

First-Line TPST-1120 Plus Atezolizumab/Bevacizumab Improves Responses in Unresectable or Metastatic HCC

October 11, 2023Chris RyanThe addition of TPST-1120 to the combination of atezolizumab and bevacizumab led to improved responses vs atezolizumab plus bevacizumab alone in the first-line treatment of p
World medicine November 23,2023
First-Line TPST-1120 Plus Atezolizumab/Bevacizumab Improves Responses in Unresectable or Metastatic HCC

First-Line TPST-1120 Plus Atezolizumab/Bevacizumab Improves Responses in Unresectable or Metastatic HCC

October 11, 2023Chris RyanThe addition of TPST-1120 to the combination of atezolizumab and bevacizumab led to improved responses vs atezolizumab plus bevacizumab alone in the first-line treatment of p
World medicine November 23,2023
Oral cancer game-changer: Researchers develop 'normalized nerve density' metric for tumor assessment

Oral cancer game-changer: Researchers develop 'normalized nerve density' metric for tumor assessment

Researchers at theUniversity of Michigan Rogel Cancer Centerand the School of Dentistry identified a new metric to articulate the relationship between nerve density and oral cancer. The st
World medicine November 23,2023
Oral cancer game-changer: Researchers develop 'normalized nerve density' metric for tumor assessment

Oral cancer game-changer: Researchers develop 'normalized nerve density' metric for tumor assessment

Researchers at theUniversity of Michigan Rogel Cancer Centerand the School of Dentistry identified a new metric to articulate the relationship between nerve density and oral cancer. The st
World medicine November 23,2023
Study reveals DCAF1 protein's role in colon cancer development through EZH2 phosphorylation

Study reveals DCAF1 protein's role in colon cancer development through EZH2 phosphorylation

Initially, the DDB1 and CUL4 Associated Factor 1 (DCAF1) was identified as a protein that interacts with human immunodeficiency virus 1 (HIV-1) virion-associated protein (Vpr) and regulates cell cycle
World medicine November 23,2023
Study reveals DCAF1 protein's role in colon cancer development through EZH2 phosphorylation

Study reveals DCAF1 protein's role in colon cancer development through EZH2 phosphorylation

Initially, the DDB1 and CUL4 Associated Factor 1 (DCAF1) was identified as a protein that interacts with human immunodeficiency virus 1 (HIV-1) virion-associated protein (Vpr) and regulates cell cycle
World medicine November 23,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com